The Medical Science Liaison (MSL) role has become crucial in pharmaceutical companies, bridging scientific research and clinical practice. Landing a first role as an MSL is not always easy, as many job postings require prior experience in the position. Pursuing specialized training focused on the MSL role and Medical Affairs can be a way to enhance one’s CV and make it more appealing to recruiters. The question is: Do these specialized courses truly provide all the tools necessary for a professional to secure their first MSL position? This survey analyzed the effectiveness and perception of MSL master’s programs in Italy.
The anonymous survey involved 28 participants, primarily from backgrounds in Biology, Biotechnology, and Pharmaceutical Chemistry and Technology (CTF), who completed an MSL master’s program after their undergraduate or doctoral studies. Among the participants, 46.4% hold a doctorate, with 32.1% earned in Italy and 14.3% abroad.
The majority of participants (85.8%) were satisfied or partially satisfied (39.3% and 46.4%, respectively) with the master’s program they attended, while only a tiny percentage, 14.2%, found it unsatisfactory. Many respondents appreciated the quality of the instructors and networking opportunities. However, the lack of industry internships was noted, suggesting the need for a more practical, operations-oriented approach to the role. Only 46.4% of respondents reported receiving practical support for CV preparation and job searching after completing the master’s program. Additionally, 53.6% highlighted the absence of structured assistance during the transition to the job market. Participants identified this as a significant shortcoming and expressed a desire for more targeted support in securing their first job. Table 1 outlines the main Pros and Cons noted by those who attended the master’s programs.
In response to the question about obtaining an MSL position after the master’s program, 57.1% of participants answered positively, with an additional 3.6% currently in the selection process. A notable finding is that 64.7% of those who secured MSL positions hold a doctorate, compared to 35.3% among those without one. Moreover, 81.8% of those who have not yet obtained an MSL position do not have a doctorate (Figure 1). These results suggest that a doctorate, combined with a specific master’s program, can significantly increase the chances of success in Medical Affairs. Additionally, a follow-up poll conducted on LinkedIn within the MSL Networking Group Italy revealed that 67% of the survey participants (8 out of 12 respondents) took a year or more to secure a position as an MSL.
Finally, survey participants highlighted that, in addition to MSL master’s programs, building a solid professional network is essential, facilitating access to meaningful opportunities and relationships in the sector. They also consider proactivity and adaptability essential. Critical skills include communication abilities, crucial for interacting with clinicians and KOLs, and a solid scientific background supported by practical experiences like internships or roles in company departments (e.g., ISF, CRA). Many participants also emphasized the importance of soft skills such as emotional intelligence, flexibility, teamwork, and a constant desire to learn, all deemed crucial for entering and thriving in Medical Affairs.
In conclusion, MSL master’s programs represent a valuable resource for acquiring technical skills and building a professional network, which is essential for entry into Medical Affairs. However, survey participants highlighted program shortcomings, including the lack of structured support for job placement and internships that provide practical field experience. Alongside training, participants consider personal qualities such as proactivity, adaptability, and soft skills essential, as well as a solid scientific foundation and communication skills for interacting with clinicians and KOLs. Securing a first MSL position is rarely immediate after completing a master’s program. Most aspiring MSLs take a year or more to land their first role. Persistence is key: don’t get discouraged, and consistently submit job applications every day!
Notably, while a doctorate combined with a master’s program increases success opportunities, about a third of participants without a doctorate have still managed to secure an MSL position at the time of this survey. This suggests that master’s programs can help individuals without a doctorate secure their first MSL role. Introducing internships or training opportunities within pharmaceutical companies could further increase this success rate.
| PROS | CONS |
| 1-Qualified and Competent Instructors: Participants praised the high level of instructors, many of whom are industry professionals or managerial figures with relevant experience, making the lessons engaging and well-structured. | 1-Lack of Internships or Guaranteed Placement: The most common limitation is the need for more structured support in finding an internship or employment. Many participants wished for a more practical path to facilitate entry into the industry. |
| 2-Networking Opportunities: A professional network of pharmaceutical company executives was appreciated as an opportunity to connect with industry professionals. | 2-High Cost: Several programs are considered too expensive compared to the benefits offered. The price seems disproportionate for those seeking an introduction or practical in-depth study. |
| 3-Flexible and Accessible Structure: Many courses are organized in weekend or online formats, catering to the needs of working individuals and providing a good overview of various corporate functions. | 3-General and Not Very Practical Content: Courses are often described as too theoretical, offering a generic overview rather than focusing on specific practical skills, such as Medical Affairs. This limitation is particularly noted by those already working in the sector. |
| 4-Overview of the Pharmaceutical Industry: Some courses provide a general informational foundation and introduce cross-functional roles, offering a comprehensive idea of how a pharmaceutical company operates. | 4-Structure Not Optimal for All Needs: Some courses, aimed at a heterogeneous audience, are less practical for those already working in the industry or with sector experience. Some participants suggest creating differentiated paths for recent graduates and professionals already in the pharmaceutical field. |
Table 1: Pros and Cons reported by participants of MSL Master’s Programs
Figure 1: Participants who secured an MSL position after a Master’s Program, with or without a PhD
About the author:
Viviana Anelli, PhD
Viviana Anelli is a Medical Science Liaison with deep expertise in rare diseases and oncology, dedicated to bridging the gap between innovative research and clinical practice. With a PhD in Biochemistry and over 23 peer-reviewed publications, she has contributed to developing therapies for acute myeloid leukemia (AML), Wilson disease, and hereditary hemolytic anemias while collaborating with leading pharmaceutical companies.
Currently, Viviana serves as the sole MSL in Italy for Agios Pharmaceuticals (via Amplity Health), where she plays a pivotal role in phase 2/3 clinical trials, fosters relationships with healthcare professionals, and supports patient advocacy initiatives. She founded MSL Networking Group Italy, the first LinkedIn networking group for Italian MSLs, and the creator of a highly regarded LinkedIn newsletter on the MSL profession.
A proactive leader and mentor, Viviana combines her scientific acumen with exceptional interpersonal and organizational skills. She drives impactful contributions to Medical Affairs and inspires the next generation of MSLs.
Have an opinion on this article? Send a message to the editor.